Puig L - Search Results

1

Cardiometabolic biomarkers in chronic plaque psoriasis before and after etanercept treatment.

Puig L, Strohal R, Fuiman J, Pedersen R, Szumski A, Koenig AS, Robertson D, Drexel H. Puig L, et al. J Dermatolog Treat. 2014 Dec;25(6):470-81. doi: 10.3109/09546634.2013.848260. Epub 2013 Nov 13. J Dermatolog Treat. 2014. PMID: 24219012 Free article. Clinical Trial.

2

Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.

Vidal D, Puig L, Gilaberte M, Alomar A. Vidal D, et al. Among authors: puig l. J Dermatolog Treat. 2004 Jun;15(3):146-52. doi: 10.1080/09546630410031909. J Dermatolog Treat. 2004. PMID: 15204146 Free article.

3

Cutaneous adverse effects of biological therapies for psoriasis.

Roé E, Puig L, Corella F, García-Navarro X, Alomar A. Roé E, et al. Among authors: puig l. Eur J Dermatol. 2008 Nov-Dec;18(6):693-9. doi: 10.1684/ejd.2008.0521. Epub 2008 Oct 27. Eur J Dermatol. 2008. PMID: 18955203

4

[Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents].

Puig L, Carrascosa JM, Daudén E, Sánchez-Carazo JL, Ferrándiz C, Sánchez-Regaña M, García-Bustinduy M, Bordas X, Moreno JC, Hernanz JM, Laguarda S, García-Patos V; Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Puig L, et al. Actas Dermosifiliogr. 2009 Jun;100(5):386-413. Actas Dermosifiliogr. 2009. PMID: 19558918 Spanish.

5

Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.

Guibal F, Iversen L, Puig L, Strohal R, Williams P. Guibal F, et al. Among authors: puig l. Curr Med Res Opin. 2009 Dec;25(12):2835-43. doi: 10.1185/03007990903320576. Curr Med Res Opin. 2009. PMID: 19916728

6

Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.

Puig L, Barco D, Vilarrasa E, Alomar A. Puig L, et al. Dermatology. 2010;220(2):154-8. doi: 10.1159/000277415. Epub 2010 Jan 26. Dermatology. 2010. PMID: 20110631 Review.

7

[Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection].

Barco D, Puig L, Alomar A. Barco D, et al. Among authors: puig l. Actas Dermosifiliogr. 2010 May;101 Suppl 1:77-81. doi: 10.1016/s0001-7310(10)70013-2. Actas Dermosifiliogr. 2010. PMID: 20492885 Review. Spanish.

8

Juvenile psoriasis and its clinical management: a European expert group consensus.

Ståhle M, Atakan N, Boehncke WH, Chimenti S, Daudén E, Giannetti A, Hoeger P, Joly P, Katsambas A, Kragballe K, Lambert J, Ortonne JP, Prinz JC, Puig L, Seyger M, Strohal R, Van De Kerkhoff P, Sterry W. Ståhle M, et al. Among authors: puig l. J Dtsch Dermatol Ges. 2010 Oct;8(10):812-8. doi: 10.1111/j.1610-0387.2010.07507.x. Epub 2010 Aug 25. J Dtsch Dermatol Ges. 2010. PMID: 20738459 English, German.

9

Treatment of severe psoriasis.

Puig L. Puig L. J Eur Acad Dermatol Venereol. 2012 Aug;26 Suppl 5:17-8. doi: 10.1111/j.1468-3083.2012.04606.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22758913

10

Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.

Puig L, Morales-Múnera CE, López-Ferrer A, Geli C. Puig L, et al. Dermatology. 2012;225(1):14-7. doi: 10.1159/000339864. Epub 2012 Aug 10. Dermatology. 2012. PMID: 22890275 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters